Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33)

קרןNational Cancer Institute/NIH
מדינהU.S.A.
סוגResearch Grants
תאריך אחרון27/09/2019
פקולטהEngineering, Exact Sciences, Life Sciences, Medicine
תיאור

This Funding Opportunity Announcement (FOA) solicits grant applications proposing exploratory research projects focused on further development and validation of emerging technologies that improve the quality of the samples used for cancer research or clinical care.

 

Funding: $300,000 per year

Duration: 3 years 

 

Research Authority due date: 10 days prior to submission 

LOI (encouraged) due dates: 7.2.19, 28.4.19, 27.8.19

Full proposal due dates: 7.3.19, 28.5.19. 27.9.19

 

קבצים מצורפים
קישורלאתר
עדכון אחרוןעדכון אחרון: 08/01/2019
אוניברסיטת תל-אביב, ת.ד. 39040, תל-אביב 6997801
UI/UX Basch_Interactive